×

Reach More Takeda Customers Where They Watch

Your customers are watching TV. Are you reaching them?

Missed Reach in a Fragmented Landscape

In June 2025, Takeda spent $6.2 million on linear TV and reached only 13.9% of its target audience, about 4 million patients at $1,545 per thousand. That means the campaign never reached 86% of potential patients. Each unexposed viewer represents a missed chance to drive awareness and influence treatment discussions.

The Invisible Patients

The charts show a strategic audience of 29 million, yet just 4 million were reached. The remaining 25 million potential patients and caregivers watched TV during the campaign but were untouched by Entyvio’s message. These unseen viewers are the hidden opportunity to inform and engage a motivated, high-value audience.

Competitors Struggle Too

Even leading brands are underdelivering. Abbvie Skyrizi reached only 19% of its TV audience, leaving 81% unreached. In immunology, no brand currently achieves full reach. The first to bridge that gap across linear and streaming will lead the category in patient visibility and trust.

Expanding Reach with TV+

With TV+, Takeda can expand Entyvio’s reach by 24% more patients at the same spend. Unified linear and connected TV planning reveals unseen audiences and reduces wasted impressions - the result: higher patient awareness, stronger adherence, and greater market impact without added cost.

Ready to Reach More Customers?

See how TV+ can transform your pharma marketing with data-driven targeting and cross-channel optimization.

Let Simulmedia Help You Reach Your Audience

Discover how TV+ can maximize your customer reach with data-driven targeting and cross-channel optimization.

🔒 Your information is secure. We respect your privacy.